HRA Pharma Sees Good Prospects For Austria

04 Feb 2020

HRA tells HBW Insight that it is seeing “a lot of growth opportunities” in the Austrian market as it takes back direct distribution of its leading consumer healthcare brands.

HRA Pharma SA has taken over distribution of its consumer healthcare brands in Austria after identifying good growth prospects in the market.

Having previously partnered with local player Sanova Pharma, HRA said it had transferred the distribution of its full portfolio in Austria to

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on HBW Insight for daily insights

Start your 7-day free trial
Explore trusted news, analysis, and insights
Access comprehensive global coverage
Enjoy instant access – no credit card required

Start Free Trial

Already a subscriber?

Danes Get OTC Access To ED Treatment

08 May 2025

• By Tom Gallen

Navamedic has launched Eroxon in Danish pharmacies giving men in the country OTC access to an ED treatment for the first time.

Haleon Targets Low Income Households In Push To Reach 1bn More Consumers

07 May 2025

• By Tom Gallen

Haleon wants to reach one billion more consumers by 2030 and plans to do this by tailoring products to those outside the highest income bracket. The UK-based firm's five-year growth plan will also see it generate £0.8bn in productivity savings.

People On The Move: Appointments At Haleon, Wellnex, Orkla

06 May 2025

• By Tom Gallen

A round-up of the latest consumer health leadership changes: Haleon names Middle East & Africa unit manager; Wellnex Life appoints interim chair; Orkla Health appoints CEO.